Xyzagen’s founder and Principal Consultant, Christopher Crean, featured on the cover article for Pharmatech Outlook Bioanalytical Services Edition, November 2020
November 11, 2020
Powering The Evolving Drug Discovery Landscape The pharmaceutical drug discovery industry is evolving. Innovations in the sector are more and more powered by seed, NIH,
